Detalhe da pesquisa
1.
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV.
Haematologica
; 104(5): 955-962, 2019 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30514803
2.
Cup-like blasts in acute myeloid leukemia.
Am J Hematol
; 90(9): 847-8, 2015 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-25615838
3.
Novel homozygous nonsense mutation in the P5'N-1 coding gene as an alternative cause for hereditary anemia with basophilic stippling.
Clin Case Rep
; 10(3): e05501, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-35280089
4.
[Platelets - what should a GP know about]. / Das sollte der Hausarzt über Thrombozyten wissen.
MMW Fortschr Med
; 160(12): 52-58, 2018 Jun.
Artigo
Alemão
| MEDLINE | ID: mdl-29943050
5.
Safe use of FOLFOX in two patients with metastatic colorectal carcinoma and severe hepatic dysfunction.
Clin Colorectal Cancer
; 10(1): E6-9, 2011 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-21609928
6.
Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP regimen (cisplatinum, etoposide, mitoxantrone and prednisone).
Ann Hematol
; 87(9): 717-26, 2008 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-18587579
7.
Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group.
Blood
; 106(12): 3725-32, 2005 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-16123223